AKT1 and colorectal cancer: Antioxidant, free radical scavengingAnticancer: suppression of NF-κB activation, modulation of PI3K/Akt/mTOR pathways in HT-29 colorectal cancer modelEnzyme inhibition: α-glucosidaseImmunomodulatory effects: inducing cytokines, modulating macrophagesyields gallic acid, hexahydroxydiphenic acid, and corilagin upon hydrolysis